Nicholas Company Inc. Makes New Investment in Amgen Inc. $AMGN

Nicholas Company Inc. has initiated a new position in Amgen Inc., acquiring 16,415 shares valued at approximately $5.37 million during the fourth quarter. This move comes as Amgen reported stronger-than-expected Q1 results and raised its full-year 2026 EPS guidance. The company also declared a quarterly dividend of $2.52 per share, though analyst sentiment remains mixed with a consensus “Hold” rating.

AMGN-3.15%
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned